Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The sodium iodide symporter (NIS) is an intrinsic plasma membrane glycoprotein that actively mediates the transport of iodide ions into cells. It plays a critical role in concentrating iodine for thyroid hormone synthesis and has been widely adopted as an imaging reporter gene for non-invasive tracking of gene expression and cell trafficking. NIS also enables targeted radioiodine therapy by concentrating therapeutic doses of beta-emitting isotopes in target tissues.
Co-transports two sodium ions (Na+) along with one iodide ion (I-) into the cytoplasm, driven by the electrochemical sodium gradient maintained by the Na+/K+-ATPase pump.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium Iodide Symporter (NIS).